ID28376A - Pirimidina yang menghambat replikasi hiv - Google Patents

Pirimidina yang menghambat replikasi hiv

Info

Publication number
ID28376A
ID28376A IDW00200101015A ID20011015A ID28376A ID 28376 A ID28376 A ID 28376A ID W00200101015 A IDW00200101015 A ID W00200101015A ID 20011015 A ID20011015 A ID 20011015A ID 28376 A ID28376 A ID 28376A
Authority
ID
Indonesia
Prior art keywords
pyyrimine
responses
hiv replication
hiv
replication
Prior art date
Application number
IDW00200101015A
Other languages
English (en)
Indonesian (id)
Inventor
Bart De Corte
Jan Heeres
Paul Adriaan Jan Janssen
Lucien M H Koymans
Marc R De Jonge
Chih Yung Ho
Robert W Kavashi
Michael J Kukla
Koen J A Van Aken
Donald W Ludovici
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26805159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID28376(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID28376A publication Critical patent/ID28376A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW00200101015A 1998-11-10 1999-09-24 Pirimidina yang menghambat replikasi hiv ID28376A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10779298P 1998-11-10 1998-11-10
US14396299P 1999-07-15 1999-07-15

Publications (1)

Publication Number Publication Date
ID28376A true ID28376A (id) 2001-05-17

Family

ID=26805159

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101015A ID28376A (id) 1998-11-10 1999-09-24 Pirimidina yang menghambat replikasi hiv

Country Status (41)

Country Link
US (5) US6878717B2 (de)
EP (2) EP1270560B1 (de)
JP (1) JP3635238B2 (de)
KR (1) KR100658489B1 (de)
CN (1) CN1214013C (de)
AP (1) AP1683A (de)
AR (1) AR024227A1 (de)
AT (2) ATE233740T1 (de)
AU (2) AU762523C (de)
BG (1) BG65103B1 (de)
BR (1) BRPI9915552B8 (de)
CA (1) CA2350801C (de)
CY (1) CY2008021I2 (de)
CZ (1) CZ301367B6 (de)
DE (3) DE69941934D1 (de)
DK (1) DK1002795T3 (de)
EA (1) EA004049B1 (de)
EE (1) EE05086B1 (de)
ES (2) ES2193664T3 (de)
FR (1) FR09C0004I2 (de)
HK (2) HK1025330A1 (de)
HR (2) HRP20010161B9 (de)
HU (2) HU230394B1 (de)
ID (1) ID28376A (de)
IL (2) IL143023A0 (de)
LT (1) LTC1002795I2 (de)
LU (1) LU91528I2 (de)
MY (1) MY121108A (de)
NL (1) NL300373I2 (de)
NO (3) NO318801B1 (de)
NZ (1) NZ511116A (de)
OA (1) OA11674A (de)
PL (1) PL204427B1 (de)
PT (1) PT1002795E (de)
SI (1) SI1002795T1 (de)
SK (2) SK287270B6 (de)
TR (1) TR200101306T2 (de)
TW (1) TWI238161B (de)
UA (1) UA70966C2 (de)
WO (1) WO2000027825A1 (de)
ZA (1) ZA200103769B (de)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004049B1 (ru) * 1998-11-10 2003-12-25 Янссен Фармацевтика Н.В. Пиримидины, ингибирующие репликацию вич
GB9914258D0 (en) * 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
WO2001022938A1 (en) * 1999-09-24 2001-04-05 Janssen Pharmaceutica N.V. Antiviral compositions
DE19945982A1 (de) * 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
WO2001025220A1 (en) 1999-10-07 2001-04-12 Amgen Inc. Triazine kinase inhibitors
WO2001060816A1 (en) 2000-02-17 2001-08-23 Amgen Inc. Kinase inhibitors
EP1282606B1 (de) 2000-05-08 2015-04-22 Janssen Pharmaceutica NV Hiv replications hemmende pyrimidinen und triazinen
CA2407754C (en) 2000-05-08 2009-09-15 Janssen Pharmaceutica N.V. Prodrugs of hiv replication inhibiting pyrimidines
WO2002056132A2 (en) * 2000-11-01 2002-07-18 Snapnames Com Inc Domain name acquisition and management system and method
US6958211B2 (en) 2001-08-08 2005-10-25 Tibotech Bvba Methods of assessing HIV integrase inhibitor therapy
US8101629B2 (en) 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US6939874B2 (en) 2001-08-22 2005-09-06 Amgen Inc. Substituted pyrimidinyl derivatives and methods of use
US7115617B2 (en) 2001-08-22 2006-10-03 Amgen Inc. Amino-substituted pyrimidinyl derivatives and methods of use
EP1453516A2 (de) 2001-10-17 2004-09-08 Boehringer Ingelheim Pharma GmbH & Co.KG 5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
CA2463989C (en) 2001-10-17 2012-01-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
BR0213792A (pt) 2001-11-01 2004-12-07 Janssen Pharmaceutica Nv Heteroaril aminas como inibidores de glicogênio sintase cinase 3beta (inibidores de gsk3)
ATE375331T1 (de) 2001-11-01 2007-10-15 Janssen Pharmaceutica Nv Amidderivate als inhibitoren der glycogensynthasekinase-3-beta
SE0104140D0 (sv) 2001-12-07 2001-12-07 Astrazeneca Ab Novel Compounds
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US7767679B2 (en) 2002-03-13 2010-08-03 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
ES2371632T3 (es) 2002-03-13 2012-01-05 Janssen Pharmaceutica N.V. Nuevos inhibidores de desacetilasa de histona.
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
EA008244B1 (ru) * 2002-05-03 2007-04-27 Янссен Фармацевтика Н.В. Полимерные микроэмульсии
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
AR040456A1 (es) 2002-06-27 2005-04-06 Bristol Myers Squibb Co Piridina n-oxidos 2,4 -disubstituidos utiles como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana
PL216744B1 (pl) 2002-07-29 2014-05-30 Rigel Pharmaceuticals Zastosowanie związku 2,4-diaminopirymidyny do wytwarzania leku do leczenia lub do zapobiegania chorobom autoimmunizacyjnym
CA2493794C (en) 2002-08-09 2010-05-25 Janssen Pharmaceutica N.V. Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
CN1703200B (zh) * 2002-09-20 2012-02-29 奥尔制药公司 隔离亚单元和相关组合物及方法
RS20050363A (en) * 2002-11-28 2007-11-15 Schering Aktiengesellschaft, Chk-,pdk-and akt-inhibitory pyrimidines,their production an use as pharmaceutical agents
EA011009B1 (ru) 2003-01-14 2008-12-30 Арена Фармасьютикалз Инк. 1,2,3-тризамещённые арильные и гетероарильные производные в качестве модуляторов метаболизма и профилактика и лечение расстройств, связанных с ним, таких как диабет и гипергликемия
CN102503903A (zh) * 2003-02-07 2012-06-20 詹森药业有限公司 抑制hiv的1,2,4-三嗪
US20070021449A1 (en) 2003-02-07 2007-01-25 Jan Heeres Pyrimidine derivatives for the prevention of hiv infection
DE602004021472D1 (en) * 2003-02-20 2009-07-23 Smithkline Beecham Corp Pyrimiidinverbindungen
CL2004000303A1 (es) * 2003-02-20 2005-04-08 Tibotec Pharm Ltd Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
CN1822843B (zh) * 2003-07-17 2010-04-28 泰博特克药品有限公司 制备含有抗病毒药物颗粒的方法
WO2005012294A1 (en) 2003-07-30 2005-02-10 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
CN100475815C (zh) * 2003-09-25 2009-04-08 詹森药业有限公司 抑制hiv复制的嘌呤衍生物
US8099262B2 (en) 2004-03-02 2012-01-17 Virco Bvba Estimation of clinical cut-offs
EP1598343A1 (de) 2004-05-19 2005-11-23 Boehringer Ingelheim International GmbH 2-Arylaminopyrimidine als PLK Inhibitoren
WO2006010750A1 (en) 2004-07-28 2006-02-02 Janssen Pharmaceutica N.V. Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
CN101035773B (zh) 2004-08-10 2012-06-06 詹森药业有限公司 抑制hiv的1,2,4-三嗪-6-酮衍生物
CA2573976C (en) * 2004-09-30 2014-04-29 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
RU2405778C2 (ru) 2004-09-30 2010-12-10 Тиботек Фармасьютикалз Лтд. 5-гетероциклилпиримидины, ингибирующие вич
BRPI0516748B8 (pt) * 2004-09-30 2021-05-25 Janssen Sciences Ireland Uc pirimidinas 5-substituídas inibidoras de hiv e composição farmacêutica que as compreende
JP5118972B2 (ja) 2004-10-29 2013-01-16 テイボテク・フアーマシユーチカルズ Ｈｉｖ阻害性二環式ピリミジン誘導体
JP2008519073A (ja) * 2004-11-08 2008-06-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チプラナビル及びエトラビリンの同時投与によるｈｉｖ感染症の治療法
US7557207B2 (en) 2004-11-24 2009-07-07 Rigel Pharmaceuticals, Inc. Spiro 2,4-pyrimidinediamine compounds and their uses
ES2337496T3 (es) 2005-01-19 2010-04-26 Rigel Pharmaceuticals, Inc. Profarmacos de compuestos de 2,4-pirimidindiamina y sus usos.
ATE523498T1 (de) * 2005-01-27 2011-09-15 Tibotec Pharm Ltd Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
DK1853588T3 (da) 2005-02-16 2008-09-15 Astrazeneca Ab Kemiske forbindelser
ES2533258T3 (es) * 2005-02-18 2015-04-08 Janssen Sciences Ireland Uc Derivados de óxido de 2-(4-cianofenilamino)pirimidina que inhiben el VIH
BRPI0609291B1 (pt) 2005-03-04 2022-02-08 Janssen Sciences Ireland Uc 2-(4-ciano-fenil)-o-hidroxilamina-pirimidinas que inibem hiv, composição farmacêutica que as compreende e processo para a preparação de ambas
CA2608009A1 (en) 2005-05-16 2006-11-23 Astrazeneca Ab Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
DK1888537T3 (da) 2005-05-26 2013-12-09 Janssen R & D Ireland Fremgangsmåde til fremstilling af 4[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitril
MX286273B (es) 2005-06-08 2011-05-04 Rigel Pharmaceuticals Inc Composiciones y metodos para inhibicion de la via jak.
US20070203161A1 (en) 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
US7754773B2 (en) * 2005-10-06 2010-07-13 University Of Massachusetts Composition and synthesis of new reagents for inhibition of HIV replication
ES2391783T3 (es) 2005-10-28 2012-11-29 Astrazeneca Ab Derivados de 4-(3-aminopirazol)pirimidina para su uso como agentes inhibidores de las tirosina cinasas en el tratamiento del cáncer
EP1981874B1 (de) 2006-01-19 2009-05-27 Janssen Pharmaceutica, N.V. Aminophenylderivate als neue inhibitoren von histondeacetylase
EP1981875B1 (de) 2006-01-19 2014-04-16 Janssen Pharmaceutica N.V. Substituierte indolyl-amino-alkyl-derivate als histon-deacetylase-inhibitoren
CN101370790B (zh) 2006-01-19 2015-10-21 詹森药业有限公司 作为组蛋白去乙酰化酶抑制剂的吡啶和嘧啶衍生物
US8962643B2 (en) 2006-02-24 2015-02-24 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
MX2008012577A (es) 2006-03-30 2008-10-10 Tibotec Pharm Ltd Pirimidinas sustituidas con 5-(hidroximetileno y aminometileno) que inhiben el virus de inmunodeficiencia humana.
AU2007233737B2 (en) * 2006-03-30 2012-11-29 Janssen Sciences Ireland Uc HIV inhibiting 5-amido substituted pyrimidines
AR060890A1 (es) 2006-05-15 2008-07-23 Boehringer Ingelheim Int Compuestos derivados de pirimidina y composicion farmaceutica en base a ellos
DK2029110T3 (da) 2006-06-06 2011-12-19 Tibotec Pharm Ltd Fremgangsmåde til fremstilling af sprøjtetørrede formuleringer med TMC125
MX2008016372A (es) 2006-06-19 2009-05-28 Alpharma Inc Composiciones farmaceuticas.
CA2665726C (en) * 2006-10-11 2016-04-19 Alpharma, Inc. Pharmaceutical compositions
EP2104491B1 (de) 2006-12-06 2017-02-22 Janssen Sciences Ireland UC Hydrobromidsalz einer anti-hiv-verbindung
BRPI0720858B8 (pt) * 2006-12-29 2021-05-25 Janssen R & D Ireland pirimidinas 6-substituídas inibidoras de hiv e composição farmacêutica que as compreende
US8318736B2 (en) 2006-12-29 2012-11-27 Janssen R&D Ireland HIV inhibiting 5,6-substituted pyrimidines
UA99459C2 (en) 2007-05-04 2012-08-27 Астразенека Аб 9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
WO2009051782A1 (en) * 2007-10-18 2009-04-23 Concert Pharmaceuticals Inc. Deuterated etravirine
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2009079521A1 (en) * 2007-12-17 2009-06-25 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
EA029131B1 (ru) 2008-05-21 2018-02-28 Ариад Фармасьютикалз, Инк. Фосфорсодержащие производные в качестве ингибиторов киназы
US11351168B1 (en) 2008-06-27 2022-06-07 Celgene Car Llc 2,4-disubstituted pyrimidines useful as kinase inhibitors
TWI458721B (zh) 2008-06-27 2014-11-01 Celgene Avilomics Res Inc 雜芳基化合物及其用途
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
UY32158A (es) * 2008-10-03 2010-04-30 Astrazeneca Ab Derivados heterociclicos y metodos de uso de los mismos
US20110071158A1 (en) * 2009-03-18 2011-03-24 Boehringer Ingelheim International Gmbh New compounds
US8754093B2 (en) 2009-03-30 2014-06-17 Janssen R&D Ireland Co-crystal of etravirine and nicotinamide
CA2760794C (en) 2009-05-05 2017-07-25 Dana Farber Cancer Institute Egfr inhibitors and methods of treating disorders
WO2010131118A2 (en) * 2009-05-12 2010-11-18 Pliva Hrvatska D.O.O. Polymorphs of etravirine and processes for preparation thereof
AP2858A (en) 2009-06-22 2014-02-28 Emcure Pharmaceuticals Ltd Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
WO2011017079A1 (en) 2009-07-27 2011-02-10 Teva Pharmaceutical Industries Ltd. Process for the preparation and purification of etravirine and intermediates thereof
GR1007010B (el) 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
SI2576541T1 (sl) 2010-06-04 2016-07-29 F. Hoffmann-La Roche Ag Aminopirimidinski derivati kot modulatorji lrrk2
CA2803848A1 (en) 2010-06-28 2012-01-05 Hetero Research Foundation A process for etravirine intermediate and polymorphs of etravirine
US8563568B2 (en) 2010-08-10 2013-10-22 Celgene Avilomics Research, Inc. Besylate salt of a BTK inhibitor
BR112013008100A2 (pt) 2010-09-22 2016-08-09 Arena Pharm Inc "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
WO2012061303A1 (en) 2010-11-01 2012-05-10 Avila Therapeutics, Inc. Heteroaryl compounds and uses thereof
WO2012061299A1 (en) 2010-11-01 2012-05-10 Avila Therapeutics, Inc. Heterocyclic compounds and uses thereof
LT3124483T (lt) 2010-11-10 2019-09-25 Genentech, Inc. Pirazolo aminopirimidino dariniai, kaip lrrk2 moduliatoriai
US8796255B2 (en) 2010-11-10 2014-08-05 Celgene Avilomics Research, Inc Mutant-selective EGFR inhibitors and uses thereof
ES2655525T3 (es) 2011-04-26 2018-02-20 Mylan Laboratories Ltd. Proceso novedoso para la preparación de Etravirina
BR112013027734A2 (pt) 2011-05-04 2017-08-08 Ariad Pharma Inc compostos para a inibição de proliferação celular em cânceres impulsionados pelo egfr, método e composição farmacêutica
WO2012170647A1 (en) * 2011-06-09 2012-12-13 Assia Chemical Industriew Ltd. Process for the preparation of etravirine and intermediates in the synthesis thereof
JP5993010B2 (ja) 2011-08-23 2016-09-14 エンドゥ ファーマシューティカルズ，インコーポレイティド ピリミド−ピリダジノン化合物及びその使用
WO2013059572A1 (en) 2011-10-19 2013-04-25 Assia Chemical Industries Ltd. Process for the preparation of etravirine and intermediates in the synthesis thereof
EP2770830A4 (de) 2011-10-28 2015-05-27 Celgene Avilomics Res Inc Verfahren zur behandlung einer bruton-tyrosinkinase-erkrankung oder -störung
US8703786B2 (en) * 2011-12-07 2014-04-22 Texas Southern University Etravirine formulations and uses thereof
PT2825042T (pt) 2012-03-15 2018-11-16 Celgene Car Llc Sais de um inibidor de cinases do recetor do fator de crescimento epidérmico
EP2825041B1 (de) 2012-03-15 2021-04-21 Celgene CAR LLC Feste formen eines epidermalen wachstumsfaktor-rezeptor-kinase-hemmers
AU2013204563B2 (en) 2012-05-05 2016-05-19 Takeda Pharmaceutical Company Limited Compounds for inhibiting cell proliferation in EGFR-driven cancers
WO2014068588A2 (en) * 2012-10-29 2014-05-08 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of etravirine and its intermediates
WO2014072419A1 (en) 2012-11-08 2014-05-15 Universiteit Antwerpen Novel anti-hiv compounds
EP2934501A4 (de) 2012-12-21 2016-06-01 Verlyx Pharma Inc Verwendungen und verfahren zur behandlung von lebererkrankungen oder -leiden
WO2014100748A1 (en) 2012-12-21 2014-06-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
ES2805359T3 (es) 2013-02-08 2021-02-11 Celgene Car Llc Inhibidores de ERK y sus usos
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
US9492471B2 (en) 2013-08-27 2016-11-15 Celgene Avilomics Research, Inc. Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
US9415049B2 (en) 2013-12-20 2016-08-16 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
US10005760B2 (en) 2014-08-13 2018-06-26 Celgene Car Llc Forms and compositions of an ERK inhibitor
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
CN104926829A (zh) * 2015-06-08 2015-09-23 山东大学 一种噻吩并嘧啶类衍生物及其制备方法和应用
EP3939965A1 (de) 2015-06-22 2022-01-19 Arena Pharmaceuticals, Inc. Kristallines l-arginin-salz von (r)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)essigsäure zur verwendung in s1p1-rezeptor-assoziierten erkrankungen
CN110066273A (zh) * 2019-06-05 2019-07-30 山东大学 一种含三氮唑环的单芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用
CA3145864A1 (en) 2019-07-03 2021-01-07 Sumitomo Dainippon Pharma Oncology, Inc. Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof
CN111217833B (zh) * 2020-02-21 2021-03-16 山东大学 噻吩并[2,3-d]嘧啶类HIV-1非核苷类逆转录酶抑制剂及其制备方法和应用
CN111875548A (zh) * 2020-07-16 2020-11-03 山东大学 一种5位芳环取代的二芳基嘧啶类衍生物及其制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
US4659363A (en) * 1983-07-25 1987-04-21 Ciba-Geigy Corporation N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof
ATE60591T1 (de) * 1984-06-25 1991-02-15 Ciba Geigy Ag Pyrimidinderivate wirksam als schaedlingsbekaempfungsmittel.
WO1989009213A1 (en) 1988-03-31 1989-10-05 Mitsubishi Kasei Corporation 6-substituted acyclicpyrimidine nucleoside derivatives and antiviral agents containing same as active ingredients
JPH02308248A (ja) 1989-05-24 1990-12-21 Fuji Photo Film Co Ltd アミノピリミジン系色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料
JP2895680B2 (ja) * 1992-07-08 1999-05-24 シャープ株式会社 磁気ヘッドおよびその製造方法
US5516775A (en) 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
WO1995010506A1 (en) 1993-10-12 1995-04-20 The Du Pont Merck Pharmaceutical Company 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
US5691364A (en) * 1995-03-10 1997-11-25 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
SK67298A3 (en) 1995-11-23 1998-11-04 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion
KR100219922B1 (ko) * 1996-05-16 1999-09-01 이서봉 신규한 항바이러스성 6-아릴옥시 및 6-아릴카르보닐 2,4-피리미딘디온 유도체 및 그의 제조 방법
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
NO311614B1 (no) * 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
GB9705361D0 (en) * 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
DE29704863U1 (de) * 1997-03-17 1997-05-22 Gesellschaft für Innenhochdruckverfahren mbH & Co. KG, 73441 Bopfingen Achsschwinge
CA2321153A1 (en) 1998-02-17 1999-08-19 Timothy D. Cushing Anti-viral pyrimidine derivatives
EP0945442A1 (de) * 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituierte Pyrimidine Derivate
DE69943247D1 (de) * 1998-03-27 2011-04-14 Janssen Pharmaceutica Nv HIV hemmende Pyrimidin Derivate
EA002973B1 (ru) 1998-03-27 2002-12-26 Янссен Фармацевтика Н.В. Производные пиримидина в качестве ингибиторов репликации вируса иммунодефицита человека
EA004049B1 (ru) * 1998-11-10 2003-12-25 Янссен Фармацевтика Н.В. Пиримидины, ингибирующие репликацию вич
CA2407754C (en) * 2000-05-08 2009-09-15 Janssen Pharmaceutica N.V. Prodrugs of hiv replication inhibiting pyrimidines

Also Published As

Publication number Publication date
DE69905683T2 (de) 2004-03-18
SK287269B6 (sk) 2010-05-07
IL169949A (en) 2011-02-28
EE200100252A (et) 2002-10-15
NO318801B1 (no) 2005-05-09
PL204427B1 (pl) 2010-01-29
IL143023A0 (en) 2002-04-21
CA2350801C (en) 2008-05-20
MY121108A (en) 2005-12-30
CA2350801A1 (en) 2000-05-18
HRP20010161A2 (en) 2002-02-28
US20110263625A1 (en) 2011-10-27
LTPA2008016I1 (lt) 2021-04-26
US8003789B2 (en) 2011-08-23
SK6032001A3 (en) 2002-01-07
ATE455107T1 (de) 2010-01-15
LTC1002795I2 (lt) 2021-06-10
LU91528I2 (fr) 2009-04-20
BR9915552B1 (pt) 2013-11-19
KR20010075235A (ko) 2001-08-09
AU2011200708A1 (en) 2011-03-10
BG65103B1 (bg) 2007-02-28
PL347586A1 (en) 2002-04-08
SK287270B6 (sk) 2010-05-07
US20030114472A1 (en) 2003-06-19
TR200101306T2 (tr) 2001-10-22
UA70966C2 (uk) 2004-11-15
NO2009003I2 (no) 2010-06-07
BRPI9915552B8 (pt) 2021-05-25
NO20011696L (no) 2001-04-04
WO2000027825A1 (en) 2000-05-18
AR024227A1 (es) 2002-09-25
HUP0104177A3 (en) 2003-01-28
US8530655B2 (en) 2013-09-10
BR9915552A (pt) 2001-08-14
ES2193664T3 (es) 2003-11-01
CN1214013C (zh) 2005-08-10
FR09C0004I2 (fr) 2010-06-11
ES2338760T3 (es) 2010-05-12
HK1048817A1 (en) 2003-04-17
US20050288278A1 (en) 2005-12-29
EP1270560B1 (de) 2010-01-13
HRP20080359A2 (en) 2008-12-31
EA200100536A1 (ru) 2002-02-28
OA11674A (en) 2005-01-12
US20040039005A1 (en) 2004-02-26
NL300373I2 (nl) 2009-04-01
FR09C0004I1 (de) 2009-02-27
CZ301367B6 (cs) 2010-02-03
JP3635238B2 (ja) 2005-04-06
NO2009003I1 (no) 2009-03-09
US6878717B2 (en) 2005-04-12
US20080176880A1 (en) 2008-07-24
EP1002795B1 (de) 2003-03-05
SI1002795T1 (en) 2003-10-31
EE05086B1 (et) 2008-10-15
DE69905683D1 (de) 2003-04-10
DK1002795T3 (da) 2003-06-30
CY2008021I1 (el) 2010-07-28
AU762523B2 (en) 2003-06-26
DE69941934D1 (de) 2010-03-04
CY2008021I2 (el) 2010-07-28
KR100658489B1 (ko) 2006-12-18
HRP20010161B1 (en) 2009-03-31
NO20011696D0 (no) 2001-04-04
EP1270560A1 (de) 2003-01-02
US7037917B2 (en) 2006-05-02
HRP20010161B9 (hr) 2014-10-24
DE122009000003I1 (de) 2009-05-20
HK1048817B (zh) 2010-04-09
HK1025330A1 (en) 2000-11-10
PT1002795E (pt) 2003-07-31
EA004049B1 (ru) 2003-12-25
CN1322198A (zh) 2001-11-14
NO2021015I1 (no) 2021-03-29
HRP20080359B1 (hr) 2016-01-01
NL300373I1 (nl) 2009-03-02
ZA200103769B (en) 2002-08-12
AP1683A (en) 2006-11-29
AU6200899A (en) 2000-05-29
BG105418A (en) 2001-11-30
NZ511116A (en) 2003-08-29
HU230394B1 (hu) 2016-04-28
CZ20011533A3 (cs) 2001-10-17
ATE233740T1 (de) 2003-03-15
AU762523C (en) 2004-02-12
TWI238161B (en) 2005-08-21
HUP0104177A2 (hu) 2002-03-28
LU91528I9 (de) 2019-01-02
HU227453B1 (en) 2011-06-28
EP1002795A1 (de) 2000-05-24
JP2002529456A (ja) 2002-09-10

Similar Documents

Publication Publication Date Title
ID28376A (id) Pirimidina yang menghambat replikasi hiv
ATE348163T1 (de) Thrombopoietin substitute
DE69936011D1 (de) Graviersystem
ATE223646T1 (de) Agrochemische formulierungen
IS5555A (is) Selekoxib lyfjablöndur
ID23546A (id) Formulasi-formulasi ziprasidon
TR199902372A3 (tr) Sulfanilsilanlar.
ID23076A (id) Popok sekali pakai
NO20004240D0 (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
ID26480A (id) Perkakas-perkakas penghubung elektromekanikal
PT1130966E (pt) Formulacoes antiparasitarias
ID23083A (id) Popok sekali pakai
DE69903524D1 (de) Pestizide hilfsmittel
DE69934191D1 (de) Bewegungshilfe
DE60135797D1 (de) Kunstleder
DE59902774D1 (de) Gravierorgan
DE69905309D1 (de) Müllverbrennungsanlage
DE69909167D1 (de) Verbrennungsvorrichtung
DE69909872D1 (de) Prägevorrichtung
NO20012476D0 (no) Rullestol
DE59911758D1 (de) Würfel
DE19981560D2 (de) Heizkessel
FR2776980B3 (fr) Monocycle perfectionne
DE59912060D1 (de) Betaine